Stay updated on Recombinant vs Marketed Flu Vaccines in Children Clinical Trial
Sign up to get notified when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.

Latest updates to the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page
- CheckyesterdayChange DetectedA minor platform revision label updated from v3.3.3 to v3.3.4. No study details or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a consolidated Locations section listing sites in Coahuila, Guerrero, Hidalgo, Jalisco, Michoacán, and Morelos, and updated the documentation to Revision 3.3.3. Removed the separate state-location entries (Coahuila Locations, Guerrero Locations, Hidalgo Locations, Jalisco Locations, Michoacán Locations, Morelos Locations) and the HHS Vulnerability Disclosure link to reflect the updated page structure.SummaryDifference0.8%

- Check51 days agoChange DetectedRevision metadata updated: v3.3.2 added and v3.2.0 removed. These are minor metadata changes and do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedThe banner about potential updates due to government funding has been removed. The page's substantive study content remains unchanged.SummaryDifference0.4%

- Check72 days agoChange DetectedThe Study Details page appears unchanged between the two screenshots; core sections such as the title, design, eligibility criteria, and outcomes are the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check101 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

Stay in the know with updates to Recombinant vs Marketed Flu Vaccines in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.